Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders

被引:38
作者
Cusin, C [1 ]
Serretti, A [1 ]
Lattuada, E [1 ]
Lilli, R [1 ]
Lorenzi, C [1 ]
Mandelli, L [1 ]
Pisati, E [1 ]
Smeraldi, E [1 ]
机构
[1] Vita Salute Univ, Ist Sci H San Raffaele, Dept Psychiat, I-20127 Milan, Italy
关键词
bipolar disorder; follow-up studies; depressive disorder; rapid cycling; genetics;
D O I
10.1016/S0022-3956(01)00026-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The aim of our study was to investigate gene variants in the long-term outcome of mood disorders. We retrospectively studied a sample of inpatients affected by recurrent and rapid cycling mood disorders. The serotonin transporter gene-linked functional polymorphic region (5-HTTLPR) and the A218C tryptophan hydroxylase (TPH) gene variant were determined using a PCR-based technique. For 5-HTTLPR polymorphism we genotyped 435 inpatients affected by major depressive (n = 153), bipolar (n = 213) and rapid cycling (n = 69) mood disorders and 456 controls; for TPH we genotyped 399 inpatients (MD, n = 132; BP, n = 203; rapid cycling n = 64) and 259 controls. Random Regression Model analysis was used to investigate the longitudinal time course of the illness. 5-HTTLPR and TPH polymorphisms were not associated with mood disorders time course. However we observed an excess of 5-HTTLPR*long alleles among rapid cycling subjects compared to both controls (P = 0.018) and remitting mood disorders (P = 0.006). TPH frequencies did not differ between mood disorders subtypes. Our results suggest that 5-HTTLPR variants may confer a susceptibility toward rapid cycling mood disorders. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 46 条
  • [31] NURNBERGER JIJ, 1988, J AFFECT DISORDERS, P15
  • [32] Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
    Pollock, BG
    Ferrell, RE
    Mulsant, BH
    Mazumdar, S
    Miller, M
    Sweet, RA
    Davis, S
    Kirshner, MA
    Houck, PR
    Stack, JA
    Reynolds, CF
    Kupfer, DJ
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) : 587 - 590
  • [33] Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT)
    Rees, M
    Norton, N
    Jones, I
    McCandless, F
    Scourfield, J
    Holmans, P
    Moorhead, S
    Feldman, E
    Sadler, S
    Cole, T
    Redman, K
    Farmer, A
    McGuffin, P
    Owen, MJ
    Craddock, N
    [J]. MOLECULAR PSYCHIATRY, 1997, 2 (05) : 398 - 402
  • [34] Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders
    Serretti, A
    Lilli, R
    Lorenzi, C
    Gasperini, M
    Smeraldi, E
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (05) : 371 - 377
  • [35] SERRETTI A, 2001, IN PRESS PSYCHIAT RE
  • [36] SERRETTI A, 2001, IN PRESS MOL PSYCHIA
  • [37] Shapira B, 1996, J CLIN PSYCHIAT, V57, P32
  • [38] Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
    Smeraldi, E
    Zanardi, R
    Benedetti, F
    Di Bella, D
    Perez, J
    Catalano, M
    [J]. MOLECULAR PSYCHIATRY, 1998, 3 (06) : 508 - 511
  • [39] Solomon DA, 1997, ARCH GEN PSYCHIAT, V54, P1001
  • [40] Spitzer R.L., 1990, STRUCTURED CLIN INTE